{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T10:07:39Z","timestamp":1763806059729,"version":"3.45.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["513781 and 1042231","513781 and 1042231"],"award-info":[{"award-number":["513781 and 1042231","513781 and 1042231"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Centre for Accelerating Diabetes Innovations"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24110-8","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:41:15Z","timestamp":1763415675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of biomarkers associated with renal decline for prediction of incident distal sensory polyneuropathy in type 2 diabetes"],"prefix":"10.1038","volume":"15","author":[{"given":"Kirsten","family":"Peters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M. E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella A.","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K.","family":"Mead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"24110_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","volume":"19","author":"CW Hicks","year":"2019","unstructured":"Hicks, C. W. & Selvin, E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr. Diab. Rep. 19, 86. https:\/\/doi.org\/10.1007\/s11892-019-1212-8 (2019).","journal-title":"Curr. Diab. Rep."},{"key":"24110_CR2","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/jgs.18338","volume":"71","author":"CW Hicks","year":"2023","unstructured":"Hicks, C. W. et al. The association of peripheral neuropathy detected by monofilament testing with risk of falls and fractures in older adults. J. Am. Geriatr. Soc. 71, 1902\u20131909. https:\/\/doi.org\/10.1111\/jgs.18338 (2023).","journal-title":"J. Am. Geriatr. Soc."},{"key":"24110_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2337\/dci22-0043","volume":"46","author":"K McDermott","year":"2023","unstructured":"McDermott, K. et al. Epidemiology, and disparities in the burden of diabetic foot ulcers. Diabetes Care. 46, 209\u2013221. https:\/\/doi.org\/10.2337\/dci22-0043 (2023).","journal-title":"Diabetes Care"},{"key":"24110_CR4","doi-asserted-by":"publisher","first-page":"14430","DOI":"10.1038\/s41598-024-65495-2","volume":"14","author":"W Perveen","year":"2024","unstructured":"Perveen, W. et al. Prevalence of peripheral neuropathy, amputation, and quality of life in patients with diabetes mellitus. Sci. Rep. 14, 14430. https:\/\/doi.org\/10.1038\/s41598-024-65495-2 (2024).","journal-title":"Sci. Rep."},{"key":"24110_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jdiacomp.2008.09.001","volume":"24","author":"Y Zhao","year":"2010","unstructured":"Zhao, Y. et al. Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. J. Diabetes Complicat. 24, 9\u201319. https:\/\/doi.org\/10.1016\/j.jdiacomp.2008.09.001 (2010).","journal-title":"J. Diabetes Complicat."},{"key":"24110_CR6","doi-asserted-by":"publisher","first-page":"1079009","DOI":"10.3389\/fendo.2023.1079009","volume":"14","author":"OE Vagi","year":"2023","unstructured":"Vagi, O. E. et al. The association between distal symmetric polyneuropathy in diabetes with all-cause mortality\u2014A meta-analysis. Front. Endocrinol. (Lausanne). 14, 1079009. https:\/\/doi.org\/10.3389\/fendo.2023.1079009 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"24110_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/WCO.0000000000000723","volume":"32","author":"DW Zochodne","year":"2019","unstructured":"Zochodne, D. W. The challenges of diabetic polyneuropathy: A brief update. Curr. Opin. Neurol. 32, 666\u2013675. https:\/\/doi.org\/10.1097\/WCO.0000000000000723 (2019).","journal-title":"Curr. Opin. Neurol."},{"key":"24110_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s001250050586","volume":"39","author":"S Tesfaye","year":"1996","unstructured":"Tesfaye, S. et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM complications study. Diabetologia 39, 1377\u20131384. https:\/\/doi.org\/10.1007\/s001250050586 (1996).","journal-title":"Diabetologia"},{"key":"24110_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/life12081185","author":"S Smith","year":"2022","unstructured":"Smith, S. et al. Prevention and management strategies for diabetic neuropathy. Life (Basel). https:\/\/doi.org\/10.3390\/life12081185 (2022).","journal-title":"Life (Basel)"},{"key":"24110_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020413","author":"ZZ Chong","year":"2025","unstructured":"Chong, Z. Z. & Souayah, N. Crumbling pathogenesis and biomarkers for diabetic peripheral neuropathy. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines13020413 (2025).","journal-title":"Biomedicines"},{"key":"24110_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40842-024-00191-8","volume":"10","author":"TME Davis","year":"2024","unstructured":"Davis, T. M. E. et al. Application of a validated prognostic plasma protein biomarker test for renal decline in type 2 diabetes to type 1 diabetes: The Fremantle diabetes study phase II. Clin. Diabetes Endocrinol. 10, 30. https:\/\/doi.org\/10.1186\/s40842-024-00191-8 (2024).","journal-title":"Clin. Diabetes Endocrinol."},{"key":"24110_CR12","doi-asserted-by":"publisher","first-page":"107406","DOI":"10.1016\/j.jdiacomp.2019.07.003","volume":"33","author":"KE Peters","year":"2019","unstructured":"Peters, K. E. et al. Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle diabetes study phase II. J. Diabetes Complicat. 33, 107406. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.07.003 (2019).","journal-title":"J. Diabetes Complicat."},{"key":"24110_CR13","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.2337\/dc17-0911","volume":"40","author":"KE Peters","year":"2017","unstructured":"Peters, K. E. et al. Identification of novel circulating biomarkers predicting rapid decline in renal function in type 2 diabetes: The Fremantle diabetes study phase II. Diabetes Care. 40, 1548\u20131555. https:\/\/doi.org\/10.2337\/dc17-0911 (2017).","journal-title":"Diabetes Care"},{"key":"24110_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1681\/ASN.V132461","volume":"13","author":"F Kronenberg","year":"2002","unstructured":"Kronenberg, F. et al. Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure. J. Am. Soc. Nephrol. 13, 461\u2013469. https:\/\/doi.org\/10.1681\/ASN.V132461 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"24110_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1530\/EC-12-0053","volume":"1","author":"RP Narayanan","year":"2012","unstructured":"Narayanan, R. P. et al. IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes. Endocr. Connect. 1, 95\u2013102. https:\/\/doi.org\/10.1530\/EC-12-0053 (2012).","journal-title":"Endocr. Connect."},{"key":"24110_CR16","doi-asserted-by":"publisher","first-page":"17805","DOI":"10.1016\/S0021-9258(18)38235-8","volume":"265","author":"JK Boyles","year":"1990","unstructured":"Boyles, J. K., Notterpek, L. M. & Anderson, L. J. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of Apolipoprotein D, Apolipoprotein A-IV, Apolipoprotein E, and Apolipoprotein A-I. J. Biol. Chem. 265, 17805\u201317815 (1990).","journal-title":"J. Biol. Chem."},{"key":"24110_CR17","doi-asserted-by":"publisher","first-page":"0135","DOI":"10.34133\/research.0135","volume":"6","author":"B Zheng","year":"2023","unstructured":"Zheng, B. et al. Unresolved excess accumulation of myelin-derived cholesterol contributes to scar formation after spinal cord injury. Res. (Wash D C. 6, 0135. https:\/\/doi.org\/10.34133\/research.0135 (2023).","journal-title":"Res. (Wash D C"},{"key":"24110_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1900\/RDS.2020.16.24","volume":"16","author":"B Biadgo","year":"2020","unstructured":"Biadgo, B., Tamir, W. & Ambachew, S. Insulin-like growth factor and its therapeutic potential for diabetes complications\u2014Mechanisms and metabolic links: A review. Rev. Diabet. Stud. 16, 24\u201334. https:\/\/doi.org\/10.1900\/RDS.2020.16.24 (2020).","journal-title":"Rev. Diabet. Stud."},{"key":"24110_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2337\/dc08-1250","volume":"32","author":"L Karvestedt","year":"2009","unstructured":"Karvestedt, L. et al. Peripheral sensory neuropathy associates with micro- or macroangiopathy: Results from a population-based study of type 2 diabetic patients in Sweden. Diabetes Care. 32, 317\u2013322. https:\/\/doi.org\/10.2337\/dc08-1250 (2009).","journal-title":"Diabetes Care"},{"key":"24110_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/qjmed\/hcz249","volume":"113","author":"YR Lai","year":"2020","unstructured":"Lai, Y. R. et al. Correlation between kidney and peripheral nerve functions in type 2 diabetes. QJM 113, 173\u2013180. https:\/\/doi.org\/10.1093\/qjmed\/hcz249 (2020).","journal-title":"QJM"},{"key":"24110_CR21","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2337\/diacare.19.11.1243","volume":"19","author":"S Savage","year":"1996","unstructured":"Savage, S., Estacio, R. O., Jeffers, B. & Schrier, R. W. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 19, 1243\u20131248. https:\/\/doi.org\/10.2337\/diacare.19.11.1243 (1996).","journal-title":"Diabetes Care"},{"key":"24110_CR22","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s13300-018-0519-9","volume":"9","author":"L Xu","year":"2018","unstructured":"Xu, L., Lin, X., Guan, M. & Liu, Y. Correlation between different stages of diabetic nephropathy and neuropathy in patients with T2DM: A cross-sectional controlled study. Diabetes Ther. 9, 2335\u20132346. https:\/\/doi.org\/10.1007\/s13300-018-0519-9 (2018).","journal-title":"Diabetes Ther."},{"key":"24110_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s10072-017-2946-1","volume":"38","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Jiang, Y., Shen, X. & Yan, S. Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus? Neurol. Sci. 38, 1381\u20131390. https:\/\/doi.org\/10.1007\/s10072-017-2946-1 (2017).","journal-title":"Neurol. Sci."},{"key":"24110_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ije\/dys065","volume":"42","author":"TM Davis","year":"2013","unstructured":"Davis, T. M., Bruce, D. G. & Davis, W. A. Cohort profile: The Fremantle diabetes study. Int. J. Epidemiol. 42, 412\u2013421. https:\/\/doi.org\/10.1093\/ije\/dys065 (2013). [doi].","journal-title":"Int. J. Epidemiol."},{"key":"24110_CR25","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","volume":"17","author":"E Feldman","year":"1994","unstructured":"Feldman, E. et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 17, 1281\u20131289 (1994).","journal-title":"Diabetes Care"},{"key":"24110_CR26","doi-asserted-by":"publisher","first-page":"e1083","DOI":"10.1210\/clinem\/dgad646","volume":"109","author":"WA Davis","year":"2024","unstructured":"Davis, W. A., Hamilton, E. & Davis, T. M. E. Temporal trends in distal symmetric polyneuropathy in type 2 diabetes: The Fremantle diabetes study. J. Clin. Endocrinol. Metab. 109, e1083\u2013e1094. https:\/\/doi.org\/10.1210\/clinem\/dgad646 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"24110_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2337\/dc16-2042","volume":"40","author":"R Pop-Busui","year":"2017","unstructured":"Pop-Busui, R. et al. Diabetic neuropathy: A position statement by the American diabetes association. Diabetes Care. 40, 136\u2013154. https:\/\/doi.org\/10.2337\/dc16-2042 (2017).","journal-title":"Diabetes Care"},{"key":"24110_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P Gaede","year":"2008","unstructured":"Gaede, P., Lund-Andersen, H., Parving, H. H. & Pedersen, O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl. J. Med. 358, 580\u2013591. https:\/\/doi.org\/10.1056\/NEJMoa0706245 (2008).","journal-title":"N Engl. J. Med."},{"key":"24110_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/proteomes8040031","author":"S Bringans","year":"2020","unstructured":"Bringans, S., Peters, K., Casey, T., Ito, J. & Lipscombe, R. The new and the old: Platform cross-validation of immunoaffinity MASS spectrometry versus ELISA for PromarkerD, a predictive test for diabetic kidney disease. Proteomes  https:\/\/doi.org\/10.3390\/proteomes8040031 (2020).","journal-title":"Proteomes"},{"key":"24110_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden, W. J. Index for rating diagnostic tests. Cancer 3, 32\u201335. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3C32::aid-cncr2820030106%3E3.0.co;2-3 (1950).","journal-title":"Cancer"},{"key":"24110_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/imj.13792","volume":"48","author":"WA Davis","year":"2018","unstructured":"Davis, W. A. et al. Prevalence of diabetes in australia: Insights from the Fremantle diabetes study phase II. Intern. Med. J. 48, 803\u2013809. https:\/\/doi.org\/10.1111\/imj.13792 (2018).","journal-title":"Intern. Med. J."},{"key":"24110_CR32","unstructured":"Kohn, M. A. & Senyak, J. Sample Size Calculators. (2025). https:\/\/www.sample-size.net\/"},{"key":"24110_CR33","doi-asserted-by":"publisher","first-page":"107853","DOI":"10.1016\/j.jdiacomp.2021.107853","volume":"35","author":"JJ Drinkwater","year":"2021","unstructured":"Drinkwater, J. J. et al. Assessment of biomarkers associated with rapid renal decline in the detection of retinopathy and its progression in type 2 diabetes: The Fremantle diabetes study phase II. J. Diabetes Complicat. 35, 107853. https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.107853 (2021).","journal-title":"J. Diabetes Complicat."},{"key":"24110_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ecl.2021.05.005","volume":"50","author":"W Crasto","year":"2021","unstructured":"Crasto, W., Patel, V., Davies, M. J. & Khunti, K. Prevention of microvascular complications of diabetes. Endocrinol. Metab. Clin. North. Am. 50, 431\u2013455. https:\/\/doi.org\/10.1016\/j.ecl.2021.05.005 (2021).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"24110_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41423-018-0088-x","volume":"16","author":"TME Davis","year":"2019","unstructured":"Davis, T. M. E., Peters, K. E. & Lipscombe, R. Apoptosis inhibitor of macrophage and diabetic kidney disease. Cell. Mol. Immunol. 16, 521. https:\/\/doi.org\/10.1038\/s41423-018-0088-x (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"24110_CR36","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/ndt\/gfv315","volume":"31","author":"JM Chillon","year":"2016","unstructured":"Chillon, J. M., Massy, Z. A. & Stengel, B. Neurological complications in chronic kidney disease patients. Nephrol. Dial Transpl. 31, 1606\u20131614. https:\/\/doi.org\/10.1093\/ndt\/gfv315 (2016).","journal-title":"Nephrol. Dial Transpl."},{"key":"24110_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/1932296820965583","volume":"16","author":"VN Dubey","year":"2022","unstructured":"Dubey, V. N., Dave, J. M., Beavis, J. & Coppini, D. V. Predicting diabetic neuropathy risk level using artificial neural network and clinical parameters of subjects with diabetes. J. Diabetes Sci. Technol. 16, 275\u2013281. https:\/\/doi.org\/10.1177\/1932296820965583 (2022).","journal-title":"J. Diabetes Sci. Technol."},{"key":"24110_CR38","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/aje\/kwh101","volume":"159","author":"MS Pepe","year":"2004","unstructured":"Pepe, M. S., Janes, H., Longton, G., Leisenring, W. & Newcomb, P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am. J. Epidemiol. 159, 882\u2013890. https:\/\/doi.org\/10.1093\/aje\/kwh101 (2004).","journal-title":"Am. J. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24110-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T10:05:00Z","timestamp":1763805900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24110-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24110"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24110-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Proteomics International and the University of Western Australia are beneficiaries of patent PCT\/AU2011\/001212 which relates to the biomarkers described in this manuscript. TMED, WAD and KEP are named as inventors of this patent. There are no other potential conflicts of interest relevant to this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40214"}}